[{"path":"/articles/Introduction.html","id":"data","dir":"Articles","previous_headings":"","what":"Data","title":"Introduction","text":"","code":"WirbelJ_2018 #> phyloseq-class experiment-level object #> otu_table()   OTU Table:         [ 530 taxa and 125 samples ] #> sample_data() Sample Data:       [ 125 samples by 137 sample variables ] #> tax_table()   Taxonomy Table:    [ 530 taxa by 6 taxonomic ranks ] #> phy_tree()    Phylogenetic Tree: [ 530 tips and 529 internal nodes ] table(sample_data(WirbelJ_2018)$disease) #>  #>     CRC healthy  #>      60      65"},{"path":[]},{"path":"/articles/Introduction.html","id":"dysbiosis-score-based-on-median-community-level-variation","dir":"Articles","previous_headings":"Dysbiosis Measures","what":"Dysbiosis score based on median community level variation","title":"Introduction","text":"Calculates median variation given sample compared reference sample group. calculate median variation sample compared reference sample set. user can provide custom distance matrix. user provides Bray-Curtis dissimilarity matrix, resulting score comparable ‘dysbiosis score’ reported Lloyd-Price J, Arze C, Ananthakrishnan et al. (2019)","code":"dist.mat <- phyloseq::distance(WirbelJ_2018, \"bray\") ref.samples <- rownames(meta(subset_samples(WirbelJ_2018, disease == \"healthy\"))) dysbiosis_1 <- dysbiosisMedianCLV(WirbelJ_2018,                                   dist_mat = dist.mat,                                   reference_samples = ref.samples) dysbiosis_1 |>    ggplot(aes(disease,score, color=disease)) +   geom_boxplot(width = 0.3, show.legend = FALSE)+   geom_jitter(width = 0.1, show.legend = FALSE) +   theme_bw()+   scale_color_manual(values = c(CRC=\"brown3\", healthy =\"steelblue\")) +   labs(x=\"\", y=\"Dysbiosis Score\")"},{"path":"/articles/Introduction.html","id":"cloud-based-locally-linear-unbiased-dysbiosis-cloud-test","dir":"Articles","previous_headings":"Dysbiosis Measures","what":"Cloud-based LOcally linear Unbiased Dysbiosis (CLOUD) test","title":"Introduction","text":"Cloud-based LOcally linear Unbiased Dysbiosis (CLOUD) test non-parametric test returns measure dysbiosis. function adapted original article Montassier E et al. 2018. , user defines set reference samples distance every sample calculated. important aspect note function method slightly modified accommodate equal number samples reference test group. calculating stats reference samples number neighbors defined number reference samples minus 1. test samples, number test samples matches number samples reference group, number neighbors also defined number reference samples minus 1. done avoid returning NAs outputs retaining maximum number reference samples. , log2Stats can used dysbiosis score.","code":"cloud.results <- cloudStatistic(WirbelJ_2018,                                 dist_mat = dist.mat,                                 reference_samples = ref.samples,                                 ndim=-1) cloud.results[1:3,1:5] #>                    stats    pvals            ids   log2Stats   study_name #> MMPU29365221ST 1.0186169 0.343750 MMPU29365221ST  0.02661160 WirbelJ_2018 #> MMPU68403337ST 0.9591212 0.625000 MMPU68403337ST -0.06021501 WirbelJ_2018 #> MMPU72854103ST 0.9914070 0.484375 MMPU72854103ST -0.01245058 WirbelJ_2018 cloud.results |>    ggplot(aes(disease, log2Stats, color=disease)) +   geom_boxplot(width = 0.3, show.legend = FALSE)+   geom_jitter(width = 0.1, show.legend = FALSE) +   theme_bw()+   scale_color_manual(values = c(CRC=\"brown3\", healthy =\"steelblue\")) +   labs(x=\"\", y=\"Dysbiosis CLOUD Score\") #> Warning: Removed 60 rows containing non-finite values (stat_boxplot). #> Warning: Removed 60 rows containing missing values (geom_point)."},{"path":"/articles/Introduction.html","id":"dysbiosis-score-based-on-euclidean-distance-to-group-centroids","dir":"Articles","previous_headings":"Dysbiosis Measures","what":"Dysbiosis score based on Euclidean distance to group centroids","title":"Introduction","text":"Calculates difference euclidean distance (ED) sample group centroids. example, sample_1 control centroid minus sample_1 case centroid. user can provide custom distance matrix. approach used AlShawaqfeh MK et al. (2017). , CentroidDist_score can used dysbiosis score.","code":"dysbiosis_2 <- euclideanDistCentroids(WirbelJ_2018,                                       dist_mat = dist.mat,                                       use_squared = TRUE,                                       group_col = \"disease\",                                       control_label = \"healthy\",                                       case_label = \"CRC\") dysbiosis_2[1:3,1:3] #>                     CentroidDist_CRC CentroidDist_healthy CentroidDist_score #> CCMD11006829ST-21-0        0.2912347            0.3684569         0.07722225 #> CCMD12232071ST-21-0        0.2744104            0.3415175         0.06710710 #> CCMD13071240ST-21-0        0.2172320            0.2697302         0.05249821 dysbiosis_2 |>    ggplot(aes(disease, CentroidDist_score, color=disease)) +   geom_boxplot(width = 0.3, show.legend = FALSE)+   geom_jitter(width = 0.1, show.legend = FALSE) +   theme_bw()+   scale_color_manual(values = c(CRC=\"brown3\", healthy =\"steelblue\")) +   labs(x=\"\", y=\"Dysbiosis CLOUD Score\") sessionInfo() #> R version 4.2.1 (2022-06-23 ucrt) #> Platform: x86_64-w64-mingw32/x64 (64-bit) #> Running under: Windows 10 x64 (build 19044) #>  #> Matrix products: default #>  #> locale: #> [1] LC_COLLATE=English_United States.utf8  #> [2] LC_CTYPE=English_United States.utf8    #> [3] LC_MONETARY=English_United States.utf8 #> [4] LC_NUMERIC=C                           #> [5] LC_TIME=English_United States.utf8     #>  #> attached base packages: #> [1] stats     graphics  grDevices utils     datasets  methods   base      #>  #> other attached packages: #> [1] dysbiosisR_0.1.0  microbiome_1.18.0 ggplot2_3.3.6     phyloseq_1.40.0   #>  #> loaded via a namespace (and not attached): #>  [1] nlme_3.1-157           bitops_1.0-7           fs_1.5.2               #>  [4] usedist_0.4.0          rprojroot_2.0.3        GenomeInfoDb_1.32.2    #>  [7] tools_4.2.1            bslib_0.4.0            utf8_1.2.2             #> [10] R6_2.5.1               vegan_2.6-2            DBI_1.1.3              #> [13] BiocGenerics_0.42.0    mgcv_1.8-40            colorspace_2.0-3       #> [16] permute_0.9-7          rhdf5filters_1.8.0     ade4_1.7-19            #> [19] withr_2.5.0            tidyselect_1.1.2       compiler_4.2.1         #> [22] textshaping_0.3.6      cli_3.3.0              Biobase_2.56.0         #> [25] desc_1.4.2             labeling_0.4.2         sass_0.4.2             #> [28] scales_1.2.1           pkgdown_2.0.6          systemfonts_1.0.4      #> [31] stringr_1.4.1          digest_0.6.29          rmarkdown_2.16         #> [34] XVector_0.36.0         pkgconfig_2.0.3        htmltools_0.5.3        #> [37] highr_0.9              fastmap_1.1.0          rlang_1.0.5            #> [40] rstudioapi_0.14        farver_2.1.1           jquerylib_0.1.4        #> [43] generics_0.1.3         jsonlite_1.8.0         dplyr_1.0.9            #> [46] RCurl_1.98-1.6         magrittr_2.0.3         GenomeInfoDbData_1.2.8 #> [49] biomformat_1.24.0      Matrix_1.5-1           Rcpp_1.0.8.3           #> [52] munsell_0.5.0          S4Vectors_0.34.0       Rhdf5lib_1.18.2        #> [55] fansi_1.0.3            ape_5.6-2              lifecycle_1.0.2        #> [58] stringi_1.7.6          yaml_2.3.5             MASS_7.3-57            #> [61] zlibbioc_1.42.0        rhdf5_2.40.0           Rtsne_0.16             #> [64] plyr_1.8.7             grid_4.2.1             parallel_4.2.1         #> [67] crayon_1.5.1           lattice_0.20-45        Biostrings_2.64.0      #> [70] splines_4.2.1          multtest_2.52.0        knitr_1.40             #> [73] pillar_1.8.1           igraph_1.3.1           reshape2_1.4.4         #> [76] codetools_0.2-18       stats4_4.2.1           glue_1.6.2             #> [79] evaluate_0.16          data.table_1.14.2      vctrs_0.4.1            #> [82] foreach_1.5.2          gtable_0.3.1           purrr_0.3.4            #> [85] tidyr_1.2.0            assertthat_0.2.1       cachem_1.0.6           #> [88] xfun_0.31              ragg_1.2.2             survival_3.3-1         #> [91] tibble_3.1.7           iterators_1.0.14       memoise_2.0.1          #> [94] IRanges_2.30.0         cluster_2.1.3          ellipsis_0.3.2"},{"path":"/authors.html","id":null,"dir":"","previous_headings":"","what":"Authors","title":"Authors and Citation","text":"Sudarshan Shetty. Author, maintainer.","code":""},{"path":"/authors.html","id":"citation","dir":"","previous_headings":"","what":"Citation","title":"Authors and Citation","text":"Shetty S (2022). dysbiosisR: Calculate Microbiome Dysbiosis. R package version 0.1.0, https://github.com/microsud/dysbiosisR.","code":"@Manual{,   title = {dysbiosisR: Calculate Microbiome Dysbiosis},   author = {Sudarshan Shetty},   year = {2022},   note = {R package version 0.1.0},   url = {https://github.com/microsud/dysbiosisR}, }"},{"path":"/index.html","id":"dysbiosisr","dir":"","previous_headings":"","what":"Calculate Microbiome Dysbiosis","title":"Calculate Microbiome Dysbiosis","text":"dysbiosisR package implements tools calculating common dysbiosis measures microbiota profiling data.","code":""},{"path":"/index.html","id":"installation","dir":"","previous_headings":"","what":"Installation","title":"Calculate Microbiome Dysbiosis","text":"can install development version dysbiosisR like :","code":"devtools::install_github(\"microsud/dysbiosisR\")"},{"path":"/index.html","id":"load-pkg","dir":"","previous_headings":"Installation","what":"Load pkg","title":"Calculate Microbiome Dysbiosis","text":"","code":"library(dysbiosisR)"},{"path":"/LICENSE.html","id":null,"dir":"","previous_headings":"","what":"GNU General Public License","title":"GNU General Public License","text":"Version 3, 29 June 2007Copyright © 2007 Free Software Foundation, Inc. <http://fsf.org/> Everyone permitted copy distribute verbatim copies license document, changing allowed.","code":""},{"path":"/LICENSE.html","id":"preamble","dir":"","previous_headings":"","what":"Preamble","title":"GNU General Public License","text":"GNU General Public License free, copyleft license software kinds works. licenses software practical works designed take away freedom share change works. contrast, GNU General Public License intended guarantee freedom share change versions program–make sure remains free software users. , Free Software Foundation, use GNU General Public License software; applies also work released way authors. can apply programs, . speak free software, referring freedom, price. General Public Licenses designed make sure freedom distribute copies free software (charge wish), receive source code can get want , can change software use pieces new free programs, know can things. protect rights, need prevent others denying rights asking surrender rights. Therefore, certain responsibilities distribute copies software, modify : responsibilities respect freedom others. example, distribute copies program, whether gratis fee, must pass recipients freedoms received. must make sure , , receive can get source code. must show terms know rights. Developers use GNU GPL protect rights two steps: (1) assert copyright software, (2) offer License giving legal permission copy, distribute /modify . developers’ authors’ protection, GPL clearly explains warranty free software. users’ authors’ sake, GPL requires modified versions marked changed, problems attributed erroneously authors previous versions. devices designed deny users access install run modified versions software inside , although manufacturer can . fundamentally incompatible aim protecting users’ freedom change software. systematic pattern abuse occurs area products individuals use, precisely unacceptable. Therefore, designed version GPL prohibit practice products. problems arise substantially domains, stand ready extend provision domains future versions GPL, needed protect freedom users. Finally, every program threatened constantly software patents. States allow patents restrict development use software general-purpose computers, , wish avoid special danger patents applied free program make effectively proprietary. prevent , GPL assures patents used render program non-free. precise terms conditions copying, distribution modification follow.","code":""},{"path":[]},{"path":"/LICENSE.html","id":"0-definitions","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"0. Definitions","title":"GNU General Public License","text":"“License” refers version 3 GNU General Public License. “Copyright” also means copyright-like laws apply kinds works, semiconductor masks. “Program” refers copyrightable work licensed License. licensee addressed “”. “Licensees” “recipients” may individuals organizations. “modify” work means copy adapt part work fashion requiring copyright permission, making exact copy. resulting work called “modified version” earlier work work “based ” earlier work. “covered work” means either unmodified Program work based Program. “propagate” work means anything , without permission, make directly secondarily liable infringement applicable copyright law, except executing computer modifying private copy. Propagation includes copying, distribution (without modification), making available public, countries activities well. “convey” work means kind propagation enables parties make receive copies. Mere interaction user computer network, transfer copy, conveying. interactive user interface displays “Appropriate Legal Notices” extent includes convenient prominently visible feature (1) displays appropriate copyright notice, (2) tells user warranty work (except extent warranties provided), licensees may convey work License, view copy License. interface presents list user commands options, menu, prominent item list meets criterion.","code":""},{"path":"/LICENSE.html","id":"1-source-code","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"1. Source Code","title":"GNU General Public License","text":"“source code” work means preferred form work making modifications . “Object code” means non-source form work. “Standard Interface” means interface either official standard defined recognized standards body, , case interfaces specified particular programming language, one widely used among developers working language. “System Libraries” executable work include anything, work whole, () included normal form packaging Major Component, part Major Component, (b) serves enable use work Major Component, implement Standard Interface implementation available public source code form. “Major Component”, context, means major essential component (kernel, window system, ) specific operating system () executable work runs, compiler used produce work, object code interpreter used run . “Corresponding Source” work object code form means source code needed generate, install, (executable work) run object code modify work, including scripts control activities. However, include work’s System Libraries, general-purpose tools generally available free programs used unmodified performing activities part work. example, Corresponding Source includes interface definition files associated source files work, source code shared libraries dynamically linked subprograms work specifically designed require, intimate data communication control flow subprograms parts work. Corresponding Source need include anything users can regenerate automatically parts Corresponding Source. Corresponding Source work source code form work.","code":""},{"path":"/LICENSE.html","id":"2-basic-permissions","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"2. Basic Permissions","title":"GNU General Public License","text":"rights granted License granted term copyright Program, irrevocable provided stated conditions met. License explicitly affirms unlimited permission run unmodified Program. output running covered work covered License output, given content, constitutes covered work. License acknowledges rights fair use equivalent, provided copyright law. may make, run propagate covered works convey, without conditions long license otherwise remains force. may convey covered works others sole purpose make modifications exclusively , provide facilities running works, provided comply terms License conveying material control copyright. thus making running covered works must exclusively behalf, direction control, terms prohibit making copies copyrighted material outside relationship . Conveying circumstances permitted solely conditions stated . Sublicensing allowed; section 10 makes unnecessary.","code":""},{"path":"/LICENSE.html","id":"3-protecting-users-legal-rights-from-anti-circumvention-law","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"3. Protecting Users’ Legal Rights From Anti-Circumvention Law","title":"GNU General Public License","text":"covered work shall deemed part effective technological measure applicable law fulfilling obligations article 11 WIPO copyright treaty adopted 20 December 1996, similar laws prohibiting restricting circumvention measures. convey covered work, waive legal power forbid circumvention technological measures extent circumvention effected exercising rights License respect covered work, disclaim intention limit operation modification work means enforcing, work’s users, third parties’ legal rights forbid circumvention technological measures.","code":""},{"path":"/LICENSE.html","id":"4-conveying-verbatim-copies","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"4. Conveying Verbatim Copies","title":"GNU General Public License","text":"may convey verbatim copies Program’s source code receive , medium, provided conspicuously appropriately publish copy appropriate copyright notice; keep intact notices stating License non-permissive terms added accord section 7 apply code; keep intact notices absence warranty; give recipients copy License along Program. may charge price price copy convey, may offer support warranty protection fee.","code":""},{"path":"/LICENSE.html","id":"5-conveying-modified-source-versions","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"5. Conveying Modified Source Versions","title":"GNU General Public License","text":"may convey work based Program, modifications produce Program, form source code terms section 4, provided also meet conditions: ) work must carry prominent notices stating modified , giving relevant date. b) work must carry prominent notices stating released License conditions added section 7. requirement modifies requirement section 4 “keep intact notices”. c) must license entire work, whole, License anyone comes possession copy. License therefore apply, along applicable section 7 additional terms, whole work, parts, regardless packaged. License gives permission license work way, invalidate permission separately received . d) work interactive user interfaces, must display Appropriate Legal Notices; however, Program interactive interfaces display Appropriate Legal Notices, work need make . compilation covered work separate independent works, nature extensions covered work, combined form larger program, volume storage distribution medium, called “aggregate” compilation resulting copyright used limit access legal rights compilation’s users beyond individual works permit. Inclusion covered work aggregate cause License apply parts aggregate.","code":""},{"path":"/LICENSE.html","id":"6-conveying-non-source-forms","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"6. Conveying Non-Source Forms","title":"GNU General Public License","text":"may convey covered work object code form terms sections 4 5, provided also convey machine-readable Corresponding Source terms License, one ways: ) Convey object code , embodied , physical product (including physical distribution medium), accompanied Corresponding Source fixed durable physical medium customarily used software interchange. b) Convey object code , embodied , physical product (including physical distribution medium), accompanied written offer, valid least three years valid long offer spare parts customer support product model, give anyone possesses object code either (1) copy Corresponding Source software product covered License, durable physical medium customarily used software interchange, price reasonable cost physically performing conveying source, (2) access copy Corresponding Source network server charge. c) Convey individual copies object code copy written offer provide Corresponding Source. alternative allowed occasionally noncommercially, received object code offer, accord subsection 6b. d) Convey object code offering access designated place (gratis charge), offer equivalent access Corresponding Source way place charge. need require recipients copy Corresponding Source along object code. place copy object code network server, Corresponding Source may different server (operated third party) supports equivalent copying facilities, provided maintain clear directions next object code saying find Corresponding Source. Regardless server hosts Corresponding Source, remain obligated ensure available long needed satisfy requirements. e) Convey object code using peer--peer transmission, provided inform peers object code Corresponding Source work offered general public charge subsection 6d. separable portion object code, whose source code excluded Corresponding Source System Library, need included conveying object code work. “User Product” either (1) “consumer product”, means tangible personal property normally used personal, family, household purposes, (2) anything designed sold incorporation dwelling. determining whether product consumer product, doubtful cases shall resolved favor coverage. particular product received particular user, “normally used” refers typical common use class product, regardless status particular user way particular user actually uses, expects expected use, product. product consumer product regardless whether product substantial commercial, industrial non-consumer uses, unless uses represent significant mode use product. “Installation Information” User Product means methods, procedures, authorization keys, information required install execute modified versions covered work User Product modified version Corresponding Source. information must suffice ensure continued functioning modified object code case prevented interfered solely modification made. convey object code work section , , specifically use , User Product, conveying occurs part transaction right possession use User Product transferred recipient perpetuity fixed term (regardless transaction characterized), Corresponding Source conveyed section must accompanied Installation Information. requirement apply neither third party retains ability install modified object code User Product (example, work installed ROM). requirement provide Installation Information include requirement continue provide support service, warranty, updates work modified installed recipient, User Product modified installed. Access network may denied modification materially adversely affects operation network violates rules protocols communication across network. Corresponding Source conveyed, Installation Information provided, accord section must format publicly documented (implementation available public source code form), must require special password key unpacking, reading copying.","code":""},{"path":"/LICENSE.html","id":"7-additional-terms","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"7. Additional Terms","title":"GNU General Public License","text":"“Additional permissions” terms supplement terms License making exceptions one conditions. Additional permissions applicable entire Program shall treated though included License, extent valid applicable law. additional permissions apply part Program, part may used separately permissions, entire Program remains governed License without regard additional permissions. convey copy covered work, may option remove additional permissions copy, part . (Additional permissions may written require removal certain cases modify work.) may place additional permissions material, added covered work, can give appropriate copyright permission. Notwithstanding provision License, material add covered work, may (authorized copyright holders material) supplement terms License terms: ) Disclaiming warranty limiting liability differently terms sections 15 16 License; b) Requiring preservation specified reasonable legal notices author attributions material Appropriate Legal Notices displayed works containing ; c) Prohibiting misrepresentation origin material, requiring modified versions material marked reasonable ways different original version; d) Limiting use publicity purposes names licensors authors material; e) Declining grant rights trademark law use trade names, trademarks, service marks; f) Requiring indemnification licensors authors material anyone conveys material (modified versions ) contractual assumptions liability recipient, liability contractual assumptions directly impose licensors authors. non-permissive additional terms considered “restrictions” within meaning section 10. Program received , part , contains notice stating governed License along term restriction, may remove term. license document contains restriction permits relicensing conveying License, may add covered work material governed terms license document, provided restriction survive relicensing conveying. add terms covered work accord section, must place, relevant source files, statement additional terms apply files, notice indicating find applicable terms. Additional terms, permissive non-permissive, may stated form separately written license, stated exceptions; requirements apply either way.","code":""},{"path":"/LICENSE.html","id":"8-termination","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"8. Termination","title":"GNU General Public License","text":"may propagate modify covered work except expressly provided License. attempt otherwise propagate modify void, automatically terminate rights License (including patent licenses granted third paragraph section 11). However, cease violation License, license particular copyright holder reinstated () provisionally, unless copyright holder explicitly finally terminates license, (b) permanently, copyright holder fails notify violation reasonable means prior 60 days cessation. Moreover, license particular copyright holder reinstated permanently copyright holder notifies violation reasonable means, first time received notice violation License (work) copyright holder, cure violation prior 30 days receipt notice. Termination rights section terminate licenses parties received copies rights License. rights terminated permanently reinstated, qualify receive new licenses material section 10.","code":""},{"path":"/LICENSE.html","id":"9-acceptance-not-required-for-having-copies","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"9. Acceptance Not Required for Having Copies","title":"GNU General Public License","text":"required accept License order receive run copy Program. Ancillary propagation covered work occurring solely consequence using peer--peer transmission receive copy likewise require acceptance. However, nothing License grants permission propagate modify covered work. actions infringe copyright accept License. Therefore, modifying propagating covered work, indicate acceptance License .","code":""},{"path":"/LICENSE.html","id":"10-automatic-licensing-of-downstream-recipients","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"10. Automatic Licensing of Downstream Recipients","title":"GNU General Public License","text":"time convey covered work, recipient automatically receives license original licensors, run, modify propagate work, subject License. responsible enforcing compliance third parties License. “entity transaction” transaction transferring control organization, substantially assets one, subdividing organization, merging organizations. propagation covered work results entity transaction, party transaction receives copy work also receives whatever licenses work party’s predecessor interest give previous paragraph, plus right possession Corresponding Source work predecessor interest, predecessor can get reasonable efforts. may impose restrictions exercise rights granted affirmed License. example, may impose license fee, royalty, charge exercise rights granted License, may initiate litigation (including cross-claim counterclaim lawsuit) alleging patent claim infringed making, using, selling, offering sale, importing Program portion .","code":""},{"path":"/LICENSE.html","id":"11-patents","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"11. Patents","title":"GNU General Public License","text":"“contributor” copyright holder authorizes use License Program work Program based. work thus licensed called contributor’s “contributor version”. contributor’s “essential patent claims” patent claims owned controlled contributor, whether already acquired hereafter acquired, infringed manner, permitted License, making, using, selling contributor version, include claims infringed consequence modification contributor version. purposes definition, “control” includes right grant patent sublicenses manner consistent requirements License. contributor grants non-exclusive, worldwide, royalty-free patent license contributor’s essential patent claims, make, use, sell, offer sale, import otherwise run, modify propagate contents contributor version. following three paragraphs, “patent license” express agreement commitment, however denominated, enforce patent (express permission practice patent covenant sue patent infringement). “grant” patent license party means make agreement commitment enforce patent party. convey covered work, knowingly relying patent license, Corresponding Source work available anyone copy, free charge terms License, publicly available network server readily accessible means, must either (1) cause Corresponding Source available, (2) arrange deprive benefit patent license particular work, (3) arrange, manner consistent requirements License, extend patent license downstream recipients. “Knowingly relying” means actual knowledge , patent license, conveying covered work country, recipient’s use covered work country, infringe one identifiable patents country reason believe valid. , pursuant connection single transaction arrangement, convey, propagate procuring conveyance , covered work, grant patent license parties receiving covered work authorizing use, propagate, modify convey specific copy covered work, patent license grant automatically extended recipients covered work works based . patent license “discriminatory” include within scope coverage, prohibits exercise , conditioned non-exercise one rights specifically granted License. may convey covered work party arrangement third party business distributing software, make payment third party based extent activity conveying work, third party grants, parties receive covered work , discriminatory patent license () connection copies covered work conveyed (copies made copies), (b) primarily connection specific products compilations contain covered work, unless entered arrangement, patent license granted, prior 28 March 2007. Nothing License shall construed excluding limiting implied license defenses infringement may otherwise available applicable patent law.","code":""},{"path":"/LICENSE.html","id":"12-no-surrender-of-others-freedom","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"12. No Surrender of Others’ Freedom","title":"GNU General Public License","text":"conditions imposed (whether court order, agreement otherwise) contradict conditions License, excuse conditions License. convey covered work satisfy simultaneously obligations License pertinent obligations, consequence may convey . example, agree terms obligate collect royalty conveying convey Program, way satisfy terms License refrain entirely conveying Program.","code":""},{"path":"/LICENSE.html","id":"13-use-with-the-gnu-affero-general-public-license","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"13. Use with the GNU Affero General Public License","title":"GNU General Public License","text":"Notwithstanding provision License, permission link combine covered work work licensed version 3 GNU Affero General Public License single combined work, convey resulting work. terms License continue apply part covered work, special requirements GNU Affero General Public License, section 13, concerning interaction network apply combination .","code":""},{"path":"/LICENSE.html","id":"14-revised-versions-of-this-license","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"14. Revised Versions of this License","title":"GNU General Public License","text":"Free Software Foundation may publish revised /new versions GNU General Public License time time. new versions similar spirit present version, may differ detail address new problems concerns. version given distinguishing version number. Program specifies certain numbered version GNU General Public License “later version” applies , option following terms conditions either numbered version later version published Free Software Foundation. Program specify version number GNU General Public License, may choose version ever published Free Software Foundation. Program specifies proxy can decide future versions GNU General Public License can used, proxy’s public statement acceptance version permanently authorizes choose version Program. Later license versions may give additional different permissions. However, additional obligations imposed author copyright holder result choosing follow later version.","code":""},{"path":"/LICENSE.html","id":"15-disclaimer-of-warranty","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"15. Disclaimer of Warranty","title":"GNU General Public License","text":"WARRANTY PROGRAM, EXTENT PERMITTED APPLICABLE LAW. EXCEPT OTHERWISE STATED WRITING COPYRIGHT HOLDERS /PARTIES PROVIDE PROGRAM “” WITHOUT WARRANTY KIND, EITHER EXPRESSED IMPLIED, INCLUDING, LIMITED , IMPLIED WARRANTIES MERCHANTABILITY FITNESS PARTICULAR PURPOSE. ENTIRE RISK QUALITY PERFORMANCE PROGRAM . PROGRAM PROVE DEFECTIVE, ASSUME COST NECESSARY SERVICING, REPAIR CORRECTION.","code":""},{"path":"/LICENSE.html","id":"16-limitation-of-liability","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"16. Limitation of Liability","title":"GNU General Public License","text":"EVENT UNLESS REQUIRED APPLICABLE LAW AGREED WRITING COPYRIGHT HOLDER, PARTY MODIFIES /CONVEYS PROGRAM PERMITTED , LIABLE DAMAGES, INCLUDING GENERAL, SPECIAL, INCIDENTAL CONSEQUENTIAL DAMAGES ARISING USE INABILITY USE PROGRAM (INCLUDING LIMITED LOSS DATA DATA RENDERED INACCURATE LOSSES SUSTAINED THIRD PARTIES FAILURE PROGRAM OPERATE PROGRAMS), EVEN HOLDER PARTY ADVISED POSSIBILITY DAMAGES.","code":""},{"path":"/LICENSE.html","id":"17-interpretation-of-sections-15-and-16","dir":"","previous_headings":"TERMS AND CONDITIONS","what":"17. Interpretation of Sections 15 and 16","title":"GNU General Public License","text":"disclaimer warranty limitation liability provided given local legal effect according terms, reviewing courts shall apply local law closely approximates absolute waiver civil liability connection Program, unless warranty assumption liability accompanies copy Program return fee. END TERMS CONDITIONS","code":""},{"path":"/LICENSE.html","id":"how-to-apply-these-terms-to-your-new-programs","dir":"","previous_headings":"","what":"How to Apply These Terms to Your New Programs","title":"GNU General Public License","text":"develop new program, want greatest possible use public, best way achieve make free software everyone can redistribute change terms. , attach following notices program. safest attach start source file effectively state exclusion warranty; file least “copyright” line pointer full notice found. Also add information contact electronic paper mail. program terminal interaction, make output short notice like starts interactive mode: hypothetical commands show w show c show appropriate parts General Public License. course, program’s commands might different; GUI interface, use “box”. also get employer (work programmer) school, , sign “copyright disclaimer” program, necessary. information , apply follow GNU GPL, see <http://www.gnu.org/licenses/>. GNU General Public License permit incorporating program proprietary programs. program subroutine library, may consider useful permit linking proprietary applications library. want , use GNU Lesser General Public License instead License. first, please read <http://www.gnu.org/philosophy/--lgpl.html>.","code":"<one line to give the program's name and a brief idea of what it does.> Copyright (C) <year>  <name of author>  This program is free software: you can redistribute it and/or modify it under the terms of the GNU General Public License as published by the Free Software Foundation, either version 3 of the License, or (at your option) any later version.  This program is distributed in the hope that it will be useful, but WITHOUT ANY WARRANTY; without even the implied warranty of MERCHANTABILITY or FITNESS FOR A PARTICULAR PURPOSE.  See the GNU General Public License for more details.  You should have received a copy of the GNU General Public License along with this program.  If not, see <http://www.gnu.org/licenses/>. <program>  Copyright (C) <year>  <name of author> This program comes with ABSOLUTELY NO WARRANTY; for details type 'show w'. This is free software, and you are welcome to redistribute it under certain conditions; type 'show c' for details."},{"path":"/reference/cloudStatistic.html","id":null,"dir":"Reference","previous_headings":"","what":"Cloud-based LOcally linear Unbiased Dysbiosis (CLOUD) test — cloudStatistic","title":"Cloud-based LOcally linear Unbiased Dysbiosis (CLOUD) test — cloudStatistic","text":"Cloud-based LOcally linear Unbiased Dysbiosis (CLOUD) test","code":""},{"path":"/reference/cloudStatistic.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Cloud-based LOcally linear Unbiased Dysbiosis (CLOUD) test — cloudStatistic","text":"x phyloseq object reference_samples Vector samples use reference. dist_mat distance matrix. Can output phyloseq::distance vegan::vegdist. ndim Dimension space data represented. Default -1. See Montassier E et al. 2018","code":""},{"path":"/reference/cloudStatistic.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Cloud-based LOcally linear Unbiased Dysbiosis (CLOUD) test — cloudStatistic","text":"data frame CLOUD stats sample information","code":""},{"path":"/reference/cloudStatistic.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Cloud-based LOcally linear Unbiased Dysbiosis (CLOUD) test — cloudStatistic","text":"Calculates CLOUD score. Cloud-based LOcally linear Unbiased Dysbiosis (CLOUD) test non-parametric test returns measure dysbiosis. function adapted original article Montassier E et al. 2018. , user defines set reference samples distance every sample calculated. important aspect note function method slightly modified accommodate equal number samples reference test group. calculating CLOUD stats reference samples number neighbors defined number reference samples minus 1. test samples, number test samples matches number samples reference group, number neighbors also defined number reference samples minus 1. done avoid returning NAs outputs retaining maximum number reference samples.","code":""},{"path":"/reference/cloudStatistic.html","id":"references","dir":"Reference","previous_headings":"","what":"References","title":"Cloud-based LOcally linear Unbiased Dysbiosis (CLOUD) test — cloudStatistic","text":"Lloyd-Price J, Arze C, Ananthakrishnan et al. (2019). Multi-omics gut microbial ecosystem inflammatory bowel diseases. Nature, 569(7758), pp.655-662. Montassier E et al. (2018). CLOUD: non-parametric detection test microbiome outliers. Microbiome, 6(1), pp.1-10.","code":""},{"path":"/reference/cloudStatistic.html","id":"author","dir":"Reference","previous_headings":"","what":"Author","title":"Cloud-based LOcally linear Unbiased Dysbiosis (CLOUD) test — cloudStatistic","text":"Sudarshan . Shetty","code":""},{"path":"/reference/cloudStatistic.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Cloud-based LOcally linear Unbiased Dysbiosis (CLOUD) test — cloudStatistic","text":"","code":"data(\"WirbelJ_2018\") library(phyloseq) ps <- WirbelJ_2018 # Define controls as reference samples ref.samples <- rownames(meta(subset_samples(ps, disease == \"healthy\"))) dist.data <- phyloseq::distance(ps, \"bray\") cloud.results <- cloudStatistic(ps,                                 dist_mat = dist.data,                                 reference_samples = ref.samples,                                 ndim=-1) head(cloud.results) #>                         stats    pvals                 ids   log2Stats #> MMPU29365221ST      1.0186169 0.343750      MMPU29365221ST  0.02661160 #> MMPU68403337ST      0.9591212 0.625000      MMPU68403337ST -0.06021501 #> MMPU72854103ST      0.9914070 0.484375      MMPU72854103ST -0.01245058 #> MMPU84450604ST      0.8871533 0.953125      MMPU84450604ST -0.17274466 #> MMPU99077057ST      0.9231189 0.765625      MMPU99077057ST -0.11541155 #> CCMD10032470ST-11-0 0.9584053 0.625000 CCMD10032470ST-11-0 -0.06129217 #>                       study_name          subject_id body_site #> MMPU29365221ST      WirbelJ_2018 CCMD11006829ST-21-0     stool #> MMPU68403337ST      WirbelJ_2018 CCMD12232071ST-21-0     stool #> MMPU72854103ST      WirbelJ_2018 CCMD13071240ST-21-0     stool #> MMPU84450604ST      WirbelJ_2018 CCMD13934959ST-21-0     stool #> MMPU99077057ST      WirbelJ_2018 CCMD14479708ST-21-0     stool #> CCMD10032470ST-11-0 WirbelJ_2018 CCMD18872694ST-21-0     stool #>                     antibiotics_current_use study_condition disease age #> MMPU29365221ST                         <NA>             CRC     CRC  42 #> MMPU68403337ST                         <NA>             CRC     CRC  75 #> MMPU72854103ST                         <NA>             CRC     CRC  66 #> MMPU84450604ST                         <NA>             CRC     CRC  56 #> MMPU99077057ST                         <NA>             CRC     CRC  74 #> CCMD10032470ST-11-0                    <NA>             CRC     CRC  63 #>                     infant_age age_category gender country non_westernized #> MMPU29365221ST              NA        adult female     DEU              no #> MMPU68403337ST              NA       senior   male     DEU              no #> MMPU72854103ST              NA       senior female     DEU              no #> MMPU84450604ST              NA        adult   male     DEU              no #> MMPU99077057ST              NA       senior   male     DEU              no #> CCMD10032470ST-11-0         NA        adult   male     DEU              no #>                     sequencing_platform DNA_extraction_kit     PMID #> MMPU29365221ST            IlluminaHiSeq              Gnome 30936547 #> MMPU68403337ST            IlluminaHiSeq              Gnome 30936547 #> MMPU72854103ST            IlluminaHiSeq              Gnome 30936547 #> MMPU84450604ST            IlluminaHiSeq              Gnome 30936547 #> MMPU99077057ST            IlluminaHiSeq              Gnome 30936547 #> CCMD10032470ST-11-0       IlluminaHiSeq              Gnome 30936547 #>                     number_reads number_bases minimum_read_length #> MMPU29365221ST          83456496   7310970279                  45 #> MMPU68403337ST          65269931   5370021950                   2 #> MMPU72854103ST          63427722   5486983593                  45 #> MMPU84450604ST          36979669   3186342244                  45 #> MMPU99077057ST          65475493   5637718108                  45 #> CCMD10032470ST-11-0     55300211   4780095276                  45 #>                     median_read_length NCBI_accession pregnant lactating #> MMPU29365221ST                      94           <NA>     <NA>      <NA> #> MMPU68403337ST                      88           <NA>     <NA>      <NA> #> MMPU72854103ST                      93           <NA>     <NA>      <NA> #> MMPU84450604ST                      93           <NA>     <NA>      <NA> #> MMPU99077057ST                      92           <NA>     <NA>      <NA> #> CCMD10032470ST-11-0                 93           <NA>     <NA>      <NA> #>                          curator BMI family days_from_first_collection #> MMPU29365221ST      Paolo_Manghi  35   <NA>                         NA #> MMPU68403337ST      Paolo_Manghi  28   <NA>                         NA #> MMPU72854103ST      Paolo_Manghi  23   <NA>                         NA #> MMPU84450604ST      Paolo_Manghi  27   <NA>                         NA #> MMPU99077057ST      Paolo_Manghi  26   <NA>                         NA #> CCMD10032470ST-11-0 Paolo_Manghi  25   <NA>                         NA #>                     family_role born_method feeding_practice travel_destination #> MMPU29365221ST             <NA>        <NA>             <NA>               <NA> #> MMPU68403337ST             <NA>        <NA>             <NA>               <NA> #> MMPU72854103ST             <NA>        <NA>             <NA>               <NA> #> MMPU84450604ST             <NA>        <NA>             <NA>               <NA> #> MMPU99077057ST             <NA>        <NA>             <NA>               <NA> #> CCMD10032470ST-11-0        <NA>        <NA>             <NA>               <NA> #>                     location visit_number premature birth_weight #> MMPU29365221ST          <NA>           NA      <NA>           NA #> MMPU68403337ST          <NA>           NA      <NA>           NA #> MMPU72854103ST          <NA>           NA      <NA>           NA #> MMPU84450604ST          <NA>           NA      <NA>           NA #> MMPU99077057ST          <NA>           NA      <NA>           NA #> CCMD10032470ST-11-0     <NA>           NA      <NA>           NA #>                     gestational_age antibiotics_family disease_subtype #> MMPU29365221ST                   NA               <NA>            <NA> #> MMPU68403337ST                   NA               <NA>            <NA> #> MMPU72854103ST                   NA               <NA>            <NA> #> MMPU84450604ST                   NA               <NA>            <NA> #> MMPU99077057ST                   NA               <NA>            <NA> #> CCMD10032470ST-11-0              NA               <NA>            <NA> #>                     days_after_onset creatine albumine hscrp ESR treatment ast #> MMPU29365221ST                    NA       NA       NA    NA  NA      <NA>  NA #> MMPU68403337ST                    NA       NA       NA    NA  NA      <NA>  NA #> MMPU72854103ST                    NA       NA       NA    NA  NA      <NA>  NA #> MMPU84450604ST                    NA       NA       NA    NA  NA      <NA>  NA #> MMPU99077057ST                    NA       NA       NA    NA  NA      <NA>  NA #> CCMD10032470ST-11-0               NA       NA       NA    NA  NA      <NA>  NA #>                     alt globulin urea_nitrogen BASDAI BASFI alcohol #> MMPU29365221ST       NA       NA            NA     NA    NA    <NA> #> MMPU68403337ST       NA       NA            NA     NA    NA    <NA> #> MMPU72854103ST       NA       NA            NA     NA    NA    <NA> #> MMPU84450604ST       NA       NA            NA     NA    NA    <NA> #> MMPU99077057ST       NA       NA            NA     NA    NA    <NA> #> CCMD10032470ST-11-0  NA       NA            NA     NA    NA    <NA> #>                     flg_genotype population menopausal_status lifestyle #> MMPU29365221ST              <NA>       <NA>              <NA>      <NA> #> MMPU68403337ST              <NA>       <NA>              <NA>      <NA> #> MMPU72854103ST              <NA>       <NA>              <NA>      <NA> #> MMPU84450604ST              <NA>       <NA>              <NA>      <NA> #> MMPU99077057ST              <NA>       <NA>              <NA>      <NA> #> CCMD10032470ST-11-0         <NA>       <NA>              <NA>      <NA> #>                     body_subsite diet    tnm triglycerides hdl ldl hba1c #> MMPU29365221ST              <NA> <NA> t3n0m0            NA  NA  NA    NA #> MMPU68403337ST              <NA> <NA> t3n2m0            NA  NA  NA    NA #> MMPU72854103ST              <NA> <NA> t3n0m0            NA  NA  NA    NA #> MMPU84450604ST              <NA> <NA> t3n0m0            NA  NA  NA    NA #> MMPU99077057ST              <NA> <NA> t3n0m1            NA  NA  NA    NA #> CCMD10032470ST-11-0         <NA> <NA> t3n1m0            NA  NA  NA    NA #>                     change_in_tumor_size RECIST  ORR smoker ever_smoker #> MMPU29365221ST                      <NA>   <NA> <NA>   <NA>        <NA> #> MMPU68403337ST                      <NA>   <NA> <NA>   <NA>        <NA> #> MMPU72854103ST                      <NA>   <NA> <NA>   <NA>        <NA> #> MMPU84450604ST                      <NA>   <NA> <NA>   <NA>        <NA> #> MMPU99077057ST                      <NA>   <NA> <NA>   <NA>        <NA> #> CCMD10032470ST-11-0                 <NA>   <NA> <NA>   <NA>        <NA> #>                     dental_sample_type history_of_periodontitis PPD_M PPD_B #> MMPU29365221ST                    <NA>                     <NA>    NA    NA #> MMPU68403337ST                    <NA>                     <NA>    NA    NA #> MMPU72854103ST                    <NA>                     <NA>    NA    NA #> MMPU84450604ST                    <NA>                     <NA>    NA    NA #> MMPU99077057ST                    <NA>                     <NA>    NA    NA #> CCMD10032470ST-11-0               <NA>                     <NA>    NA    NA #>                     PPD_D PPD_L fobt disease_stage disease_location #> MMPU29365221ST         NA    NA <NA>          <NA>             <NA> #> MMPU68403337ST         NA    NA <NA>          <NA>             <NA> #> MMPU72854103ST         NA    NA <NA>          <NA>             <NA> #> MMPU84450604ST         NA    NA <NA>          <NA>             <NA> #> MMPU99077057ST         NA    NA <NA>          <NA>             <NA> #> CCMD10032470ST-11-0    NA    NA <NA>          <NA>             <NA> #>                     calprotectin HBI SCCAI uncurated_metadata mumps cholesterol #> MMPU29365221ST                NA  NA    NA               <NA>  <NA>          NA #> MMPU68403337ST                NA  NA    NA               <NA>  <NA>          NA #> MMPU72854103ST                NA  NA    NA               <NA>  <NA>          NA #> MMPU84450604ST                NA  NA    NA               <NA>  <NA>          NA #> MMPU99077057ST                NA  NA    NA               <NA>  <NA>          NA #> CCMD10032470ST-11-0           NA  NA    NA               <NA>  <NA>          NA #>                     c_peptide glucose creatinine bilubirin prothrombin_time wbc #> MMPU29365221ST             NA      NA         NA        NA               NA  NA #> MMPU68403337ST             NA      NA         NA        NA               NA  NA #> MMPU72854103ST             NA      NA         NA        NA               NA  NA #> MMPU84450604ST             NA      NA         NA        NA               NA  NA #> MMPU99077057ST             NA      NA         NA        NA               NA  NA #> CCMD10032470ST-11-0        NA      NA         NA        NA               NA  NA #>                     rbc hemoglobinometry remission dyastolic_p systolic_p #> MMPU29365221ST       NA               NA      <NA>          NA         NA #> MMPU68403337ST       NA               NA      <NA>          NA         NA #> MMPU72854103ST       NA               NA      <NA>          NA         NA #> MMPU84450604ST       NA               NA      <NA>          NA         NA #> MMPU99077057ST       NA               NA      <NA>          NA         NA #> CCMD10032470ST-11-0  NA               NA      <NA>          NA         NA #>                     insulin_cat adiponectin glp_1 cd163 il_1 leptin fgf_19 #> MMPU29365221ST             <NA>          NA    NA    NA   NA     NA     NA #> MMPU68403337ST             <NA>          NA    NA    NA   NA     NA     NA #> MMPU72854103ST             <NA>          NA    NA    NA   NA     NA     NA #> MMPU84450604ST             <NA>          NA    NA    NA   NA     NA     NA #> MMPU99077057ST             <NA>          NA    NA    NA   NA     NA     NA #> CCMD10032470ST-11-0        <NA>          NA    NA    NA   NA     NA     NA #>                     glutamate_decarboxylase_2_antibody  HLA #> MMPU29365221ST                                      NA <NA> #> MMPU68403337ST                                      NA <NA> #> MMPU72854103ST                                      NA <NA> #> MMPU84450604ST                                      NA <NA> #> MMPU99077057ST                                      NA <NA> #> CCMD10032470ST-11-0                                 NA <NA> #>                     autoantibody_positive age_seroconversion age_T1D_diagnosis #> MMPU29365221ST                       <NA>                 NA                NA #> MMPU68403337ST                       <NA>                 NA                NA #> MMPU72854103ST                       <NA>                 NA                NA #> MMPU84450604ST                       <NA>                 NA                NA #> MMPU99077057ST                       <NA>                 NA                NA #> CCMD10032470ST-11-0                  <NA>                 NA                NA #>                     hitchip_probe_class subcohort previous_therapy #> MMPU29365221ST                     <NA>      <NA>             <NA> #> MMPU68403337ST                     <NA>      <NA>             <NA> #> MMPU72854103ST                     <NA>      <NA>             <NA> #> MMPU84450604ST                     <NA>      <NA>             <NA> #> MMPU99077057ST                     <NA>      <NA>             <NA> #> CCMD10032470ST-11-0                <NA>      <NA>             <NA> #>                     performance_status toxicity_above_zero PFS12 #> MMPU29365221ST                      NA                <NA>  <NA> #> MMPU68403337ST                      NA                <NA>  <NA> #> MMPU72854103ST                      NA                <NA>  <NA> #> MMPU84450604ST                      NA                <NA>  <NA> #> MMPU99077057ST                      NA                <NA>  <NA> #> CCMD10032470ST-11-0                 NA                <NA>  <NA> #>                     fasting_insulin fasting_glucose protein_intake stec_count #> MMPU29365221ST                   NA              NA             NA       <NA> #> MMPU68403337ST                   NA              NA             NA       <NA> #> MMPU72854103ST                   NA              NA             NA       <NA> #> MMPU84450604ST                   NA              NA             NA       <NA> #> MMPU99077057ST                   NA              NA             NA       <NA> #> CCMD10032470ST-11-0              NA              NA             NA       <NA> #>                     shigatoxin_2_elisa stool_texture anti_PD_1 mgs_richness #> MMPU29365221ST                    <NA>          <NA>      <NA>           NA #> MMPU68403337ST                    <NA>          <NA>      <NA>           NA #> MMPU72854103ST                    <NA>          <NA>      <NA>           NA #> MMPU84450604ST                    <NA>          <NA>      <NA>           NA #> MMPU99077057ST                    <NA>          <NA>      <NA>           NA #> CCMD10032470ST-11-0               <NA>          <NA>      <NA>           NA #>                     ferm_milk_prod_consumer inr ctp birth_control_pil #> MMPU29365221ST                         <NA>  NA  NA              <NA> #> MMPU68403337ST                         <NA>  NA  NA              <NA> #> MMPU72854103ST                         <NA>  NA  NA              <NA> #> MMPU84450604ST                         <NA>  NA  NA              <NA> #> MMPU99077057ST                         <NA>  NA  NA              <NA> #> CCMD10032470ST-11-0                    <NA>  NA  NA              <NA> #>                     c_section_type ajcc hla_drb12 hla_dqa12 hla_dqa11 hla_drb11 #> MMPU29365221ST                <NA>   ii        NA        NA        NA        NA #> MMPU68403337ST                <NA>  iii        NA        NA        NA        NA #> MMPU72854103ST                <NA>   ii        NA        NA        NA        NA #> MMPU84450604ST                <NA>   ii        NA        NA        NA        NA #> MMPU99077057ST                <NA>   iv        NA        NA        NA        NA #> CCMD10032470ST-11-0           <NA>  iii        NA        NA        NA        NA #>                     zigosity brinkman_index alcohol_numeric #> MMPU29365221ST          <NA>             NA              NA #> MMPU68403337ST          <NA>             NA              NA #> MMPU72854103ST          <NA>             NA              NA #> MMPU84450604ST          <NA>             NA              NA #> MMPU99077057ST          <NA>             NA              NA #> CCMD10032470ST-11-0     <NA>             NA              NA #>                     breastfeeding_duration formula_first_day ALT eGFR nspecies #> MMPU29365221ST                          NA                NA  NA   NA      144 #> MMPU68403337ST                          NA                NA  NA   NA      110 #> MMPU72854103ST                          NA                NA  NA   NA      126 #> MMPU84450604ST                          NA                NA  NA   NA      100 #> MMPU99077057ST                          NA                NA  NA   NA      110 #> CCMD10032470ST-11-0                     NA                NA  NA   NA      145 #>                     group #> MMPU29365221ST       case #> MMPU68403337ST       case #> MMPU72854103ST       case #> MMPU84450604ST       case #> MMPU99077057ST       case #> CCMD10032470ST-11-0  case"},{"path":"/reference/dysbiosisMedianCLV.html","id":null,"dir":"Reference","previous_headings":"","what":"Dysbiosis Score Based on Median Community Level Variation — dysbiosisMedianCLV","title":"Dysbiosis Score Based on Median Community Level Variation — dysbiosisMedianCLV","text":"Dysbiosis Score Based Median Community Level Variation","code":""},{"path":"/reference/dysbiosisMedianCLV.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Dysbiosis Score Based on Median Community Level Variation — dysbiosisMedianCLV","text":"x phyloseq object dist_mat distance matrix. Can output phyloseq::distance vegan::vegdist. reference_samples Vector samples use reference.","code":""},{"path":"/reference/dysbiosisMedianCLV.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Dysbiosis Score Based on Median Community Level Variation — dysbiosisMedianCLV","text":"data frame Median CLV values sample information","code":""},{"path":"/reference/dysbiosisMedianCLV.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Dysbiosis Score Based on Median Community Level Variation — dysbiosisMedianCLV","text":"Calculates median variation given sample compared reference          sample group. dysbiosisMedianCLV calculate median          variation sample compared reference sample set. user          can provide custom distance matrix. user provides Bray-Curtis          dissimilarity matrix, resulting score comparable          dysbiosis score reported          Lloyd-Price J, Arze C, Ananthakrishnan et al. (2019).","code":""},{"path":"/reference/dysbiosisMedianCLV.html","id":"references","dir":"Reference","previous_headings":"","what":"References","title":"Dysbiosis Score Based on Median Community Level Variation — dysbiosisMedianCLV","text":"Lloyd-Price J, Arze C, Ananthakrishnan et al. (2019). Multi-omics gut microbial ecosystem inflammatory bowel diseases. Nature, 569(7758), pp.655-662.","code":""},{"path":"/reference/dysbiosisMedianCLV.html","id":"author","dir":"Reference","previous_headings":"","what":"Author","title":"Dysbiosis Score Based on Median Community Level Variation — dysbiosisMedianCLV","text":"Sudarshan . Shetty","code":""},{"path":"/reference/dysbiosisMedianCLV.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Dysbiosis Score Based on Median Community Level Variation — dysbiosisMedianCLV","text":"","code":"library(dysbiosisR) # We use WirbelJ_2018 as test data dist.mat <- phyloseq::distance(WirbelJ_2018, \"bray\") ref.samples <- rownames(meta(subset_samples(WirbelJ_2018, disease == \"healthy\"))) db.1 <- dysbiosisMedianCLV(WirbelJ_2018,                            dist_mat = dist.mat,                            reference_samples = ref.samples)  head(db.1) #>                         score   study_name          subject_id body_site #> CCMD11006829ST-21-0 0.7698956 WirbelJ_2018 CCMD11006829ST-21-0     stool #> CCMD12232071ST-21-0 0.7611880 WirbelJ_2018 CCMD12232071ST-21-0     stool #> CCMD13071240ST-21-0 0.6879019 WirbelJ_2018 CCMD13071240ST-21-0     stool #> CCMD13934959ST-21-0 0.6536472 WirbelJ_2018 CCMD13934959ST-21-0     stool #> CCMD14479708ST-21-0 0.6524941 WirbelJ_2018 CCMD14479708ST-21-0     stool #> CCMD18872694ST-21-0 0.6241206 WirbelJ_2018 CCMD18872694ST-21-0     stool #>                     antibiotics_current_use study_condition disease age #> CCMD11006829ST-21-0                    <NA>             CRC     CRC  42 #> CCMD12232071ST-21-0                    <NA>             CRC     CRC  75 #> CCMD13071240ST-21-0                    <NA>             CRC     CRC  66 #> CCMD13934959ST-21-0                    <NA>             CRC     CRC  56 #> CCMD14479708ST-21-0                    <NA>             CRC     CRC  74 #> CCMD18872694ST-21-0                    <NA>             CRC     CRC  63 #>                     infant_age age_category gender country non_westernized #> CCMD11006829ST-21-0         NA        adult female     DEU              no #> CCMD12232071ST-21-0         NA       senior   male     DEU              no #> CCMD13071240ST-21-0         NA       senior female     DEU              no #> CCMD13934959ST-21-0         NA        adult   male     DEU              no #> CCMD14479708ST-21-0         NA       senior   male     DEU              no #> CCMD18872694ST-21-0         NA        adult   male     DEU              no #>                     sequencing_platform DNA_extraction_kit     PMID #> CCMD11006829ST-21-0       IlluminaHiSeq              Gnome 30936547 #> CCMD12232071ST-21-0       IlluminaHiSeq              Gnome 30936547 #> CCMD13071240ST-21-0       IlluminaHiSeq              Gnome 30936547 #> CCMD13934959ST-21-0       IlluminaHiSeq              Gnome 30936547 #> CCMD14479708ST-21-0       IlluminaHiSeq              Gnome 30936547 #> CCMD18872694ST-21-0       IlluminaHiSeq              Gnome 30936547 #>                     number_reads number_bases minimum_read_length #> CCMD11006829ST-21-0     83456496   7310970279                  45 #> CCMD12232071ST-21-0     65269931   5370021950                   2 #> CCMD13071240ST-21-0     63427722   5486983593                  45 #> CCMD13934959ST-21-0     36979669   3186342244                  45 #> CCMD14479708ST-21-0     65475493   5637718108                  45 #> CCMD18872694ST-21-0     55300211   4780095276                  45 #>                     median_read_length NCBI_accession pregnant lactating #> CCMD11006829ST-21-0                 94           <NA>     <NA>      <NA> #> CCMD12232071ST-21-0                 88           <NA>     <NA>      <NA> #> CCMD13071240ST-21-0                 93           <NA>     <NA>      <NA> #> CCMD13934959ST-21-0                 93           <NA>     <NA>      <NA> #> CCMD14479708ST-21-0                 92           <NA>     <NA>      <NA> #> CCMD18872694ST-21-0                 93           <NA>     <NA>      <NA> #>                          curator BMI family days_from_first_collection #> CCMD11006829ST-21-0 Paolo_Manghi  35   <NA>                         NA #> CCMD12232071ST-21-0 Paolo_Manghi  28   <NA>                         NA #> CCMD13071240ST-21-0 Paolo_Manghi  23   <NA>                         NA #> CCMD13934959ST-21-0 Paolo_Manghi  27   <NA>                         NA #> CCMD14479708ST-21-0 Paolo_Manghi  26   <NA>                         NA #> CCMD18872694ST-21-0 Paolo_Manghi  25   <NA>                         NA #>                     family_role born_method feeding_practice travel_destination #> CCMD11006829ST-21-0        <NA>        <NA>             <NA>               <NA> #> CCMD12232071ST-21-0        <NA>        <NA>             <NA>               <NA> #> CCMD13071240ST-21-0        <NA>        <NA>             <NA>               <NA> #> CCMD13934959ST-21-0        <NA>        <NA>             <NA>               <NA> #> CCMD14479708ST-21-0        <NA>        <NA>             <NA>               <NA> #> CCMD18872694ST-21-0        <NA>        <NA>             <NA>               <NA> #>                     location visit_number premature birth_weight #> CCMD11006829ST-21-0     <NA>           NA      <NA>           NA #> CCMD12232071ST-21-0     <NA>           NA      <NA>           NA #> CCMD13071240ST-21-0     <NA>           NA      <NA>           NA #> CCMD13934959ST-21-0     <NA>           NA      <NA>           NA #> CCMD14479708ST-21-0     <NA>           NA      <NA>           NA #> CCMD18872694ST-21-0     <NA>           NA      <NA>           NA #>                     gestational_age antibiotics_family disease_subtype #> CCMD11006829ST-21-0              NA               <NA>            <NA> #> CCMD12232071ST-21-0              NA               <NA>            <NA> #> CCMD13071240ST-21-0              NA               <NA>            <NA> #> CCMD13934959ST-21-0              NA               <NA>            <NA> #> CCMD14479708ST-21-0              NA               <NA>            <NA> #> CCMD18872694ST-21-0              NA               <NA>            <NA> #>                     days_after_onset creatine albumine hscrp ESR treatment ast #> CCMD11006829ST-21-0               NA       NA       NA    NA  NA      <NA>  NA #> CCMD12232071ST-21-0               NA       NA       NA    NA  NA      <NA>  NA #> CCMD13071240ST-21-0               NA       NA       NA    NA  NA      <NA>  NA #> CCMD13934959ST-21-0               NA       NA       NA    NA  NA      <NA>  NA #> CCMD14479708ST-21-0               NA       NA       NA    NA  NA      <NA>  NA #> CCMD18872694ST-21-0               NA       NA       NA    NA  NA      <NA>  NA #>                     alt globulin urea_nitrogen BASDAI BASFI alcohol #> CCMD11006829ST-21-0  NA       NA            NA     NA    NA    <NA> #> CCMD12232071ST-21-0  NA       NA            NA     NA    NA    <NA> #> CCMD13071240ST-21-0  NA       NA            NA     NA    NA    <NA> #> CCMD13934959ST-21-0  NA       NA            NA     NA    NA    <NA> #> CCMD14479708ST-21-0  NA       NA            NA     NA    NA    <NA> #> CCMD18872694ST-21-0  NA       NA            NA     NA    NA    <NA> #>                     flg_genotype population menopausal_status lifestyle #> CCMD11006829ST-21-0         <NA>       <NA>              <NA>      <NA> #> CCMD12232071ST-21-0         <NA>       <NA>              <NA>      <NA> #> CCMD13071240ST-21-0         <NA>       <NA>              <NA>      <NA> #> CCMD13934959ST-21-0         <NA>       <NA>              <NA>      <NA> #> CCMD14479708ST-21-0         <NA>       <NA>              <NA>      <NA> #> CCMD18872694ST-21-0         <NA>       <NA>              <NA>      <NA> #>                     body_subsite diet    tnm triglycerides hdl ldl hba1c #> CCMD11006829ST-21-0         <NA> <NA> t3n0m0            NA  NA  NA    NA #> CCMD12232071ST-21-0         <NA> <NA> t3n2m0            NA  NA  NA    NA #> CCMD13071240ST-21-0         <NA> <NA> t3n0m0            NA  NA  NA    NA #> CCMD13934959ST-21-0         <NA> <NA> t3n0m0            NA  NA  NA    NA #> CCMD14479708ST-21-0         <NA> <NA> t3n0m1            NA  NA  NA    NA #> CCMD18872694ST-21-0         <NA> <NA> t3n1m0            NA  NA  NA    NA #>                     change_in_tumor_size RECIST  ORR smoker ever_smoker #> CCMD11006829ST-21-0                 <NA>   <NA> <NA>   <NA>        <NA> #> CCMD12232071ST-21-0                 <NA>   <NA> <NA>   <NA>        <NA> #> CCMD13071240ST-21-0                 <NA>   <NA> <NA>   <NA>        <NA> #> CCMD13934959ST-21-0                 <NA>   <NA> <NA>   <NA>        <NA> #> CCMD14479708ST-21-0                 <NA>   <NA> <NA>   <NA>        <NA> #> CCMD18872694ST-21-0                 <NA>   <NA> <NA>   <NA>        <NA> #>                     dental_sample_type history_of_periodontitis PPD_M PPD_B #> CCMD11006829ST-21-0               <NA>                     <NA>    NA    NA #> CCMD12232071ST-21-0               <NA>                     <NA>    NA    NA #> CCMD13071240ST-21-0               <NA>                     <NA>    NA    NA #> CCMD13934959ST-21-0               <NA>                     <NA>    NA    NA #> CCMD14479708ST-21-0               <NA>                     <NA>    NA    NA #> CCMD18872694ST-21-0               <NA>                     <NA>    NA    NA #>                     PPD_D PPD_L fobt disease_stage disease_location #> CCMD11006829ST-21-0    NA    NA <NA>          <NA>             <NA> #> CCMD12232071ST-21-0    NA    NA <NA>          <NA>             <NA> #> CCMD13071240ST-21-0    NA    NA <NA>          <NA>             <NA> #> CCMD13934959ST-21-0    NA    NA <NA>          <NA>             <NA> #> CCMD14479708ST-21-0    NA    NA <NA>          <NA>             <NA> #> CCMD18872694ST-21-0    NA    NA <NA>          <NA>             <NA> #>                     calprotectin HBI SCCAI uncurated_metadata mumps cholesterol #> CCMD11006829ST-21-0           NA  NA    NA               <NA>  <NA>          NA #> CCMD12232071ST-21-0           NA  NA    NA               <NA>  <NA>          NA #> CCMD13071240ST-21-0           NA  NA    NA               <NA>  <NA>          NA #> CCMD13934959ST-21-0           NA  NA    NA               <NA>  <NA>          NA #> CCMD14479708ST-21-0           NA  NA    NA               <NA>  <NA>          NA #> CCMD18872694ST-21-0           NA  NA    NA               <NA>  <NA>          NA #>                     c_peptide glucose creatinine bilubirin prothrombin_time wbc #> CCMD11006829ST-21-0        NA      NA         NA        NA               NA  NA #> CCMD12232071ST-21-0        NA      NA         NA        NA               NA  NA #> CCMD13071240ST-21-0        NA      NA         NA        NA               NA  NA #> CCMD13934959ST-21-0        NA      NA         NA        NA               NA  NA #> CCMD14479708ST-21-0        NA      NA         NA        NA               NA  NA #> CCMD18872694ST-21-0        NA      NA         NA        NA               NA  NA #>                     rbc hemoglobinometry remission dyastolic_p systolic_p #> CCMD11006829ST-21-0  NA               NA      <NA>          NA         NA #> CCMD12232071ST-21-0  NA               NA      <NA>          NA         NA #> CCMD13071240ST-21-0  NA               NA      <NA>          NA         NA #> CCMD13934959ST-21-0  NA               NA      <NA>          NA         NA #> CCMD14479708ST-21-0  NA               NA      <NA>          NA         NA #> CCMD18872694ST-21-0  NA               NA      <NA>          NA         NA #>                     insulin_cat adiponectin glp_1 cd163 il_1 leptin fgf_19 #> CCMD11006829ST-21-0        <NA>          NA    NA    NA   NA     NA     NA #> CCMD12232071ST-21-0        <NA>          NA    NA    NA   NA     NA     NA #> CCMD13071240ST-21-0        <NA>          NA    NA    NA   NA     NA     NA #> CCMD13934959ST-21-0        <NA>          NA    NA    NA   NA     NA     NA #> CCMD14479708ST-21-0        <NA>          NA    NA    NA   NA     NA     NA #> CCMD18872694ST-21-0        <NA>          NA    NA    NA   NA     NA     NA #>                     glutamate_decarboxylase_2_antibody  HLA #> CCMD11006829ST-21-0                                 NA <NA> #> CCMD12232071ST-21-0                                 NA <NA> #> CCMD13071240ST-21-0                                 NA <NA> #> CCMD13934959ST-21-0                                 NA <NA> #> CCMD14479708ST-21-0                                 NA <NA> #> CCMD18872694ST-21-0                                 NA <NA> #>                     autoantibody_positive age_seroconversion age_T1D_diagnosis #> CCMD11006829ST-21-0                  <NA>                 NA                NA #> CCMD12232071ST-21-0                  <NA>                 NA                NA #> CCMD13071240ST-21-0                  <NA>                 NA                NA #> CCMD13934959ST-21-0                  <NA>                 NA                NA #> CCMD14479708ST-21-0                  <NA>                 NA                NA #> CCMD18872694ST-21-0                  <NA>                 NA                NA #>                     hitchip_probe_class subcohort previous_therapy #> CCMD11006829ST-21-0                <NA>      <NA>             <NA> #> CCMD12232071ST-21-0                <NA>      <NA>             <NA> #> CCMD13071240ST-21-0                <NA>      <NA>             <NA> #> CCMD13934959ST-21-0                <NA>      <NA>             <NA> #> CCMD14479708ST-21-0                <NA>      <NA>             <NA> #> CCMD18872694ST-21-0                <NA>      <NA>             <NA> #>                     performance_status toxicity_above_zero PFS12 #> CCMD11006829ST-21-0                 NA                <NA>  <NA> #> CCMD12232071ST-21-0                 NA                <NA>  <NA> #> CCMD13071240ST-21-0                 NA                <NA>  <NA> #> CCMD13934959ST-21-0                 NA                <NA>  <NA> #> CCMD14479708ST-21-0                 NA                <NA>  <NA> #> CCMD18872694ST-21-0                 NA                <NA>  <NA> #>                     fasting_insulin fasting_glucose protein_intake stec_count #> CCMD11006829ST-21-0              NA              NA             NA       <NA> #> CCMD12232071ST-21-0              NA              NA             NA       <NA> #> CCMD13071240ST-21-0              NA              NA             NA       <NA> #> CCMD13934959ST-21-0              NA              NA             NA       <NA> #> CCMD14479708ST-21-0              NA              NA             NA       <NA> #> CCMD18872694ST-21-0              NA              NA             NA       <NA> #>                     shigatoxin_2_elisa stool_texture anti_PD_1 mgs_richness #> CCMD11006829ST-21-0               <NA>          <NA>      <NA>           NA #> CCMD12232071ST-21-0               <NA>          <NA>      <NA>           NA #> CCMD13071240ST-21-0               <NA>          <NA>      <NA>           NA #> CCMD13934959ST-21-0               <NA>          <NA>      <NA>           NA #> CCMD14479708ST-21-0               <NA>          <NA>      <NA>           NA #> CCMD18872694ST-21-0               <NA>          <NA>      <NA>           NA #>                     ferm_milk_prod_consumer inr ctp birth_control_pil #> CCMD11006829ST-21-0                    <NA>  NA  NA              <NA> #> CCMD12232071ST-21-0                    <NA>  NA  NA              <NA> #> CCMD13071240ST-21-0                    <NA>  NA  NA              <NA> #> CCMD13934959ST-21-0                    <NA>  NA  NA              <NA> #> CCMD14479708ST-21-0                    <NA>  NA  NA              <NA> #> CCMD18872694ST-21-0                    <NA>  NA  NA              <NA> #>                     c_section_type ajcc hla_drb12 hla_dqa12 hla_dqa11 hla_drb11 #> CCMD11006829ST-21-0           <NA>   ii        NA        NA        NA        NA #> CCMD12232071ST-21-0           <NA>  iii        NA        NA        NA        NA #> CCMD13071240ST-21-0           <NA>   ii        NA        NA        NA        NA #> CCMD13934959ST-21-0           <NA>   ii        NA        NA        NA        NA #> CCMD14479708ST-21-0           <NA>   iv        NA        NA        NA        NA #> CCMD18872694ST-21-0           <NA>  iii        NA        NA        NA        NA #>                     zigosity brinkman_index alcohol_numeric #> CCMD11006829ST-21-0     <NA>             NA              NA #> CCMD12232071ST-21-0     <NA>             NA              NA #> CCMD13071240ST-21-0     <NA>             NA              NA #> CCMD13934959ST-21-0     <NA>             NA              NA #> CCMD14479708ST-21-0     <NA>             NA              NA #> CCMD18872694ST-21-0     <NA>             NA              NA #>                     breastfeeding_duration formula_first_day ALT eGFR nspecies #> CCMD11006829ST-21-0                     NA                NA  NA   NA      144 #> CCMD12232071ST-21-0                     NA                NA  NA   NA      110 #> CCMD13071240ST-21-0                     NA                NA  NA   NA      126 #> CCMD13934959ST-21-0                     NA                NA  NA   NA      100 #> CCMD14479708ST-21-0                     NA                NA  NA   NA      110 #> CCMD18872694ST-21-0                     NA                NA  NA   NA      145 #>                     group #> CCMD11006829ST-21-0  case #> CCMD12232071ST-21-0  case #> CCMD13071240ST-21-0  case #> CCMD13934959ST-21-0  case #> CCMD14479708ST-21-0  case #> CCMD18872694ST-21-0  case"},{"path":"/reference/euclideanDistCentroids.html","id":null,"dir":"Reference","previous_headings":"","what":"Dysbiosis Score Based on Euclidean Distance to Group Centroids — euclideanDistCentroids","title":"Dysbiosis Score Based on Euclidean Distance to Group Centroids — euclideanDistCentroids","text":"Dysbiosis Score Based Euclidean Distance Group Centroids","code":""},{"path":"/reference/euclideanDistCentroids.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Dysbiosis Score Based on Euclidean Distance to Group Centroids — euclideanDistCentroids","text":"x phyloseq object dist_mat distance matrix. Can output phyloseq::distance vegan::vegdist. use_squared Logical. Default FALSE. TURE score calculated using squared distance group centroids. see usedist::dist_to_centroids. group_col column phyloseq::sample_data control case labels. control_label character string specifying control/healthy labels group_col. case_label character string specifying case/disease labels group_col.","code":""},{"path":"/reference/euclideanDistCentroids.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Dysbiosis Score Based on Euclidean Distance to Group Centroids — euclideanDistCentroids","text":"data frame Centroid distance group score         sample information","code":""},{"path":"/reference/euclideanDistCentroids.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Dysbiosis Score Based on Euclidean Distance to Group Centroids — euclideanDistCentroids","text":"Calculates difference euclidean distance (ED) sample          group centroids. example, sample_1 control centroid minus          sample_1 case centroid. user can provide custom distance          matrix. approach used AlShawaqfeh MK et al. (2017).","code":""},{"path":"/reference/euclideanDistCentroids.html","id":"references","dir":"Reference","previous_headings":"","what":"References","title":"Dysbiosis Score Based on Euclidean Distance to Group Centroids — euclideanDistCentroids","text":"AlShawaqfeh MK et al. (2017). dysbiosis index assess microbial changes fecal samples dogs chronic inflammatory enteropathy. FEMS microbiology ecology, 93(11), p.fix136.","code":""},{"path":"/reference/euclideanDistCentroids.html","id":"author","dir":"Reference","previous_headings":"","what":"Author","title":"Dysbiosis Score Based on Euclidean Distance to Group Centroids — euclideanDistCentroids","text":"Sudarshan . Shetty","code":""},{"path":"/reference/euclideanDistCentroids.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Dysbiosis Score Based on Euclidean Distance to Group Centroids — euclideanDistCentroids","text":"","code":"library(dysbiosisR) # We use WirbelJ_2018 as test data dist.mat <- phyloseq::distance(WirbelJ_2018, \"bray\") db.1 <- euclideanDistCentroids(WirbelJ_2018,                                dist_mat = dist.mat,                                use_squared = TRUE,                                group_col = \"disease\",                                control_label = \"healthy\",                                case_label = \"CRC\")  head(db.1) #>                     CentroidDist_CRC CentroidDist_healthy CentroidDist_score #> CCMD11006829ST-21-0        0.2912347            0.3684569        0.077222248 #> CCMD12232071ST-21-0        0.2744104            0.3415175        0.067107098 #> CCMD13071240ST-21-0        0.2172320            0.2697302        0.052498215 #> CCMD13934959ST-21-0        0.1578083            0.2092996        0.051491262 #> CCMD14479708ST-21-0        0.2095968            0.2218744        0.012277622 #> CCMD18872694ST-21-0        0.1859037            0.1906539        0.004750221 #>                       study_name          subject_id body_site #> CCMD11006829ST-21-0 WirbelJ_2018 CCMD11006829ST-21-0     stool #> CCMD12232071ST-21-0 WirbelJ_2018 CCMD12232071ST-21-0     stool #> CCMD13071240ST-21-0 WirbelJ_2018 CCMD13071240ST-21-0     stool #> CCMD13934959ST-21-0 WirbelJ_2018 CCMD13934959ST-21-0     stool #> CCMD14479708ST-21-0 WirbelJ_2018 CCMD14479708ST-21-0     stool #> CCMD18872694ST-21-0 WirbelJ_2018 CCMD18872694ST-21-0     stool #>                     antibiotics_current_use study_condition disease age #> CCMD11006829ST-21-0                    <NA>             CRC     CRC  42 #> CCMD12232071ST-21-0                    <NA>             CRC     CRC  75 #> CCMD13071240ST-21-0                    <NA>             CRC     CRC  66 #> CCMD13934959ST-21-0                    <NA>             CRC     CRC  56 #> CCMD14479708ST-21-0                    <NA>             CRC     CRC  74 #> CCMD18872694ST-21-0                    <NA>             CRC     CRC  63 #>                     infant_age age_category gender country non_westernized #> CCMD11006829ST-21-0         NA        adult female     DEU              no #> CCMD12232071ST-21-0         NA       senior   male     DEU              no #> CCMD13071240ST-21-0         NA       senior female     DEU              no #> CCMD13934959ST-21-0         NA        adult   male     DEU              no #> CCMD14479708ST-21-0         NA       senior   male     DEU              no #> CCMD18872694ST-21-0         NA        adult   male     DEU              no #>                     sequencing_platform DNA_extraction_kit     PMID #> CCMD11006829ST-21-0       IlluminaHiSeq              Gnome 30936547 #> CCMD12232071ST-21-0       IlluminaHiSeq              Gnome 30936547 #> CCMD13071240ST-21-0       IlluminaHiSeq              Gnome 30936547 #> CCMD13934959ST-21-0       IlluminaHiSeq              Gnome 30936547 #> CCMD14479708ST-21-0       IlluminaHiSeq              Gnome 30936547 #> CCMD18872694ST-21-0       IlluminaHiSeq              Gnome 30936547 #>                     number_reads number_bases minimum_read_length #> CCMD11006829ST-21-0     83456496   7310970279                  45 #> CCMD12232071ST-21-0     65269931   5370021950                   2 #> CCMD13071240ST-21-0     63427722   5486983593                  45 #> CCMD13934959ST-21-0     36979669   3186342244                  45 #> CCMD14479708ST-21-0     65475493   5637718108                  45 #> CCMD18872694ST-21-0     55300211   4780095276                  45 #>                     median_read_length NCBI_accession pregnant lactating #> CCMD11006829ST-21-0                 94           <NA>     <NA>      <NA> #> CCMD12232071ST-21-0                 88           <NA>     <NA>      <NA> #> CCMD13071240ST-21-0                 93           <NA>     <NA>      <NA> #> CCMD13934959ST-21-0                 93           <NA>     <NA>      <NA> #> CCMD14479708ST-21-0                 92           <NA>     <NA>      <NA> #> CCMD18872694ST-21-0                 93           <NA>     <NA>      <NA> #>                          curator BMI family days_from_first_collection #> CCMD11006829ST-21-0 Paolo_Manghi  35   <NA>                         NA #> CCMD12232071ST-21-0 Paolo_Manghi  28   <NA>                         NA #> CCMD13071240ST-21-0 Paolo_Manghi  23   <NA>                         NA #> CCMD13934959ST-21-0 Paolo_Manghi  27   <NA>                         NA #> CCMD14479708ST-21-0 Paolo_Manghi  26   <NA>                         NA #> CCMD18872694ST-21-0 Paolo_Manghi  25   <NA>                         NA #>                     family_role born_method feeding_practice travel_destination #> CCMD11006829ST-21-0        <NA>        <NA>             <NA>               <NA> #> CCMD12232071ST-21-0        <NA>        <NA>             <NA>               <NA> #> CCMD13071240ST-21-0        <NA>        <NA>             <NA>               <NA> #> CCMD13934959ST-21-0        <NA>        <NA>             <NA>               <NA> #> CCMD14479708ST-21-0        <NA>        <NA>             <NA>               <NA> #> CCMD18872694ST-21-0        <NA>        <NA>             <NA>               <NA> #>                     location visit_number premature birth_weight #> CCMD11006829ST-21-0     <NA>           NA      <NA>           NA #> CCMD12232071ST-21-0     <NA>           NA      <NA>           NA #> CCMD13071240ST-21-0     <NA>           NA      <NA>           NA #> CCMD13934959ST-21-0     <NA>           NA      <NA>           NA #> CCMD14479708ST-21-0     <NA>           NA      <NA>           NA #> CCMD18872694ST-21-0     <NA>           NA      <NA>           NA #>                     gestational_age antibiotics_family disease_subtype #> CCMD11006829ST-21-0              NA               <NA>            <NA> #> CCMD12232071ST-21-0              NA               <NA>            <NA> #> CCMD13071240ST-21-0              NA               <NA>            <NA> #> CCMD13934959ST-21-0              NA               <NA>            <NA> #> CCMD14479708ST-21-0              NA               <NA>            <NA> #> CCMD18872694ST-21-0              NA               <NA>            <NA> #>                     days_after_onset creatine albumine hscrp ESR treatment ast #> CCMD11006829ST-21-0               NA       NA       NA    NA  NA      <NA>  NA #> CCMD12232071ST-21-0               NA       NA       NA    NA  NA      <NA>  NA #> CCMD13071240ST-21-0               NA       NA       NA    NA  NA      <NA>  NA #> CCMD13934959ST-21-0               NA       NA       NA    NA  NA      <NA>  NA #> CCMD14479708ST-21-0               NA       NA       NA    NA  NA      <NA>  NA #> CCMD18872694ST-21-0               NA       NA       NA    NA  NA      <NA>  NA #>                     alt globulin urea_nitrogen BASDAI BASFI alcohol #> CCMD11006829ST-21-0  NA       NA            NA     NA    NA    <NA> #> CCMD12232071ST-21-0  NA       NA            NA     NA    NA    <NA> #> CCMD13071240ST-21-0  NA       NA            NA     NA    NA    <NA> #> CCMD13934959ST-21-0  NA       NA            NA     NA    NA    <NA> #> CCMD14479708ST-21-0  NA       NA            NA     NA    NA    <NA> #> CCMD18872694ST-21-0  NA       NA            NA     NA    NA    <NA> #>                     flg_genotype population menopausal_status lifestyle #> CCMD11006829ST-21-0         <NA>       <NA>              <NA>      <NA> #> CCMD12232071ST-21-0         <NA>       <NA>              <NA>      <NA> #> CCMD13071240ST-21-0         <NA>       <NA>              <NA>      <NA> #> CCMD13934959ST-21-0         <NA>       <NA>              <NA>      <NA> #> CCMD14479708ST-21-0         <NA>       <NA>              <NA>      <NA> #> CCMD18872694ST-21-0         <NA>       <NA>              <NA>      <NA> #>                     body_subsite diet    tnm triglycerides hdl ldl hba1c #> CCMD11006829ST-21-0         <NA> <NA> t3n0m0            NA  NA  NA    NA #> CCMD12232071ST-21-0         <NA> <NA> t3n2m0            NA  NA  NA    NA #> CCMD13071240ST-21-0         <NA> <NA> t3n0m0            NA  NA  NA    NA #> CCMD13934959ST-21-0         <NA> <NA> t3n0m0            NA  NA  NA    NA #> CCMD14479708ST-21-0         <NA> <NA> t3n0m1            NA  NA  NA    NA #> CCMD18872694ST-21-0         <NA> <NA> t3n1m0            NA  NA  NA    NA #>                     change_in_tumor_size RECIST  ORR smoker ever_smoker #> CCMD11006829ST-21-0                 <NA>   <NA> <NA>   <NA>        <NA> #> CCMD12232071ST-21-0                 <NA>   <NA> <NA>   <NA>        <NA> #> CCMD13071240ST-21-0                 <NA>   <NA> <NA>   <NA>        <NA> #> CCMD13934959ST-21-0                 <NA>   <NA> <NA>   <NA>        <NA> #> CCMD14479708ST-21-0                 <NA>   <NA> <NA>   <NA>        <NA> #> CCMD18872694ST-21-0                 <NA>   <NA> <NA>   <NA>        <NA> #>                     dental_sample_type history_of_periodontitis PPD_M PPD_B #> CCMD11006829ST-21-0               <NA>                     <NA>    NA    NA #> CCMD12232071ST-21-0               <NA>                     <NA>    NA    NA #> CCMD13071240ST-21-0               <NA>                     <NA>    NA    NA #> CCMD13934959ST-21-0               <NA>                     <NA>    NA    NA #> CCMD14479708ST-21-0               <NA>                     <NA>    NA    NA #> CCMD18872694ST-21-0               <NA>                     <NA>    NA    NA #>                     PPD_D PPD_L fobt disease_stage disease_location #> CCMD11006829ST-21-0    NA    NA <NA>          <NA>             <NA> #> CCMD12232071ST-21-0    NA    NA <NA>          <NA>             <NA> #> CCMD13071240ST-21-0    NA    NA <NA>          <NA>             <NA> #> CCMD13934959ST-21-0    NA    NA <NA>          <NA>             <NA> #> CCMD14479708ST-21-0    NA    NA <NA>          <NA>             <NA> #> CCMD18872694ST-21-0    NA    NA <NA>          <NA>             <NA> #>                     calprotectin HBI SCCAI uncurated_metadata mumps cholesterol #> CCMD11006829ST-21-0           NA  NA    NA               <NA>  <NA>          NA #> CCMD12232071ST-21-0           NA  NA    NA               <NA>  <NA>          NA #> CCMD13071240ST-21-0           NA  NA    NA               <NA>  <NA>          NA #> CCMD13934959ST-21-0           NA  NA    NA               <NA>  <NA>          NA #> CCMD14479708ST-21-0           NA  NA    NA               <NA>  <NA>          NA #> CCMD18872694ST-21-0           NA  NA    NA               <NA>  <NA>          NA #>                     c_peptide glucose creatinine bilubirin prothrombin_time wbc #> CCMD11006829ST-21-0        NA      NA         NA        NA               NA  NA #> CCMD12232071ST-21-0        NA      NA         NA        NA               NA  NA #> CCMD13071240ST-21-0        NA      NA         NA        NA               NA  NA #> CCMD13934959ST-21-0        NA      NA         NA        NA               NA  NA #> CCMD14479708ST-21-0        NA      NA         NA        NA               NA  NA #> CCMD18872694ST-21-0        NA      NA         NA        NA               NA  NA #>                     rbc hemoglobinometry remission dyastolic_p systolic_p #> CCMD11006829ST-21-0  NA               NA      <NA>          NA         NA #> CCMD12232071ST-21-0  NA               NA      <NA>          NA         NA #> CCMD13071240ST-21-0  NA               NA      <NA>          NA         NA #> CCMD13934959ST-21-0  NA               NA      <NA>          NA         NA #> CCMD14479708ST-21-0  NA               NA      <NA>          NA         NA #> CCMD18872694ST-21-0  NA               NA      <NA>          NA         NA #>                     insulin_cat adiponectin glp_1 cd163 il_1 leptin fgf_19 #> CCMD11006829ST-21-0        <NA>          NA    NA    NA   NA     NA     NA #> CCMD12232071ST-21-0        <NA>          NA    NA    NA   NA     NA     NA #> CCMD13071240ST-21-0        <NA>          NA    NA    NA   NA     NA     NA #> CCMD13934959ST-21-0        <NA>          NA    NA    NA   NA     NA     NA #> CCMD14479708ST-21-0        <NA>          NA    NA    NA   NA     NA     NA #> CCMD18872694ST-21-0        <NA>          NA    NA    NA   NA     NA     NA #>                     glutamate_decarboxylase_2_antibody  HLA #> CCMD11006829ST-21-0                                 NA <NA> #> CCMD12232071ST-21-0                                 NA <NA> #> CCMD13071240ST-21-0                                 NA <NA> #> CCMD13934959ST-21-0                                 NA <NA> #> CCMD14479708ST-21-0                                 NA <NA> #> CCMD18872694ST-21-0                                 NA <NA> #>                     autoantibody_positive age_seroconversion age_T1D_diagnosis #> CCMD11006829ST-21-0                  <NA>                 NA                NA #> CCMD12232071ST-21-0                  <NA>                 NA                NA #> CCMD13071240ST-21-0                  <NA>                 NA                NA #> CCMD13934959ST-21-0                  <NA>                 NA                NA #> CCMD14479708ST-21-0                  <NA>                 NA                NA #> CCMD18872694ST-21-0                  <NA>                 NA                NA #>                     hitchip_probe_class subcohort previous_therapy #> CCMD11006829ST-21-0                <NA>      <NA>             <NA> #> CCMD12232071ST-21-0                <NA>      <NA>             <NA> #> CCMD13071240ST-21-0                <NA>      <NA>             <NA> #> CCMD13934959ST-21-0                <NA>      <NA>             <NA> #> CCMD14479708ST-21-0                <NA>      <NA>             <NA> #> CCMD18872694ST-21-0                <NA>      <NA>             <NA> #>                     performance_status toxicity_above_zero PFS12 #> CCMD11006829ST-21-0                 NA                <NA>  <NA> #> CCMD12232071ST-21-0                 NA                <NA>  <NA> #> CCMD13071240ST-21-0                 NA                <NA>  <NA> #> CCMD13934959ST-21-0                 NA                <NA>  <NA> #> CCMD14479708ST-21-0                 NA                <NA>  <NA> #> CCMD18872694ST-21-0                 NA                <NA>  <NA> #>                     fasting_insulin fasting_glucose protein_intake stec_count #> CCMD11006829ST-21-0              NA              NA             NA       <NA> #> CCMD12232071ST-21-0              NA              NA             NA       <NA> #> CCMD13071240ST-21-0              NA              NA             NA       <NA> #> CCMD13934959ST-21-0              NA              NA             NA       <NA> #> CCMD14479708ST-21-0              NA              NA             NA       <NA> #> CCMD18872694ST-21-0              NA              NA             NA       <NA> #>                     shigatoxin_2_elisa stool_texture anti_PD_1 mgs_richness #> CCMD11006829ST-21-0               <NA>          <NA>      <NA>           NA #> CCMD12232071ST-21-0               <NA>          <NA>      <NA>           NA #> CCMD13071240ST-21-0               <NA>          <NA>      <NA>           NA #> CCMD13934959ST-21-0               <NA>          <NA>      <NA>           NA #> CCMD14479708ST-21-0               <NA>          <NA>      <NA>           NA #> CCMD18872694ST-21-0               <NA>          <NA>      <NA>           NA #>                     ferm_milk_prod_consumer inr ctp birth_control_pil #> CCMD11006829ST-21-0                    <NA>  NA  NA              <NA> #> CCMD12232071ST-21-0                    <NA>  NA  NA              <NA> #> CCMD13071240ST-21-0                    <NA>  NA  NA              <NA> #> CCMD13934959ST-21-0                    <NA>  NA  NA              <NA> #> CCMD14479708ST-21-0                    <NA>  NA  NA              <NA> #> CCMD18872694ST-21-0                    <NA>  NA  NA              <NA> #>                     c_section_type ajcc hla_drb12 hla_dqa12 hla_dqa11 hla_drb11 #> CCMD11006829ST-21-0           <NA>   ii        NA        NA        NA        NA #> CCMD12232071ST-21-0           <NA>  iii        NA        NA        NA        NA #> CCMD13071240ST-21-0           <NA>   ii        NA        NA        NA        NA #> CCMD13934959ST-21-0           <NA>   ii        NA        NA        NA        NA #> CCMD14479708ST-21-0           <NA>   iv        NA        NA        NA        NA #> CCMD18872694ST-21-0           <NA>  iii        NA        NA        NA        NA #>                     zigosity brinkman_index alcohol_numeric #> CCMD11006829ST-21-0     <NA>             NA              NA #> CCMD12232071ST-21-0     <NA>             NA              NA #> CCMD13071240ST-21-0     <NA>             NA              NA #> CCMD13934959ST-21-0     <NA>             NA              NA #> CCMD14479708ST-21-0     <NA>             NA              NA #> CCMD18872694ST-21-0     <NA>             NA              NA #>                     breastfeeding_duration formula_first_day ALT eGFR nspecies #> CCMD11006829ST-21-0                     NA                NA  NA   NA      144 #> CCMD12232071ST-21-0                     NA                NA  NA   NA      110 #> CCMD13071240ST-21-0                     NA                NA  NA   NA      126 #> CCMD13934959ST-21-0                     NA                NA  NA   NA      100 #> CCMD14479708ST-21-0                     NA                NA  NA   NA      110 #> CCMD18872694ST-21-0                     NA                NA  NA   NA      145 #>                     group #> CCMD11006829ST-21-0  case #> CCMD12232071ST-21-0  case #> CCMD13071240ST-21-0  case #> CCMD13934959ST-21-0  case #> CCMD14479708ST-21-0  case #> CCMD18872694ST-21-0  case"},{"path":"/reference/WirbelJ_2018.html","id":null,"dir":"Reference","previous_headings":"","what":"WirbelJ 2018 CRC data — WirbelJ_2018","title":"WirbelJ 2018 CRC data — WirbelJ_2018","text":"WirbelJ , et al. (2018) data authors investigated              CRC microbiome comparison healthy controls.","code":""},{"path":"/reference/WirbelJ_2018.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"WirbelJ 2018 CRC data — WirbelJ_2018","text":"","code":"data(WirbelJ_2018)"},{"path":"/reference/WirbelJ_2018.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"WirbelJ 2018 CRC data — WirbelJ_2018","text":"Phyloseq object","code":""},{"path":"/reference/WirbelJ_2018.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"WirbelJ 2018 CRC data — WirbelJ_2018","text":"Loads data set R.","code":""},{"path":"/reference/WirbelJ_2018.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"WirbelJ 2018 CRC data — WirbelJ_2018","text":"WirbelJ_2018 obtained curatedMetagenomicData          consists 530 taxa (species-level) 125 samples. include          60 CRC 65 healthy samples. data relative abundances.","code":""},{"path":"/reference/WirbelJ_2018.html","id":"references","dir":"Reference","previous_headings":"","what":"References","title":"WirbelJ 2018 CRC data — WirbelJ_2018","text":"Wirbel, Jakob, et al. (2018) Meta-analysis fecal metagenomes         reveals global microbial signatures specific colorectal         cancer.        Nature medicine, 25(4), pp.679-689.        https://doi.org/10.1038/s41591-019-0406-6","code":""},{"path":"/reference/WirbelJ_2018.html","id":"author","dir":"Reference","previous_headings":"","what":"Author","title":"WirbelJ 2018 CRC data — WirbelJ_2018","text":"Sudarshan Shetty sudarshanshetty9@gmail.com","code":""},{"path":"/news/index.html","id":"dysbiosisr-010","dir":"Changelog","previous_headings":"","what":"dysbiosisR 0.1.0","title":"dysbiosisR 0.1.0","text":"Added NEWS.md file track changes package.","code":""}]
